HCAT — HEALTH CATALYST INC

Ownership history in Pathstone Holdings, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which Pathstone Holdings, LLC reported a position in HEALTH CATALYST INC (HCAT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 27,752 -171 -0.6% 0.00% $79K $2.85
2025 Q2 ADDED 27,923 +355 +1.3% 0.00% $105K $3.77
2025 Q1 REDUCED 27,568 -948 -3.3% 0.00% $125K $4.53
2024 Q4 INITIATED 28,516 — — 0.00% $202K $7.07
% of Fund (quarterly)    HCAT price (monthly, adj. close)

Other funds also holding HCAT

As of 2025 Q4 — sorted by position size

Whetstone Capital Advisors, LLC 3Y 7Y 2.8% First Light Asset Management, LLC 3Y 7Y 2.36% Nepsis Inc. 3Y 7Y 1.41% Palogic Value Management, L.P. 3Y 1.27% HighMark Wealth Management LLC 3Y 0.72% MARTIN & CO INC /TN/ 3Y 7Y 0.21% PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.07% CVS HEALTH Corp 3Y 0.06% nVerses Capital, LLC 0.06% Williams & Novak, LLC 0.05%
← Back to Pathstone Holdings, LLC Holdings